GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40698)

  • GC81660 structure
    GC81660GAPDH siRNA Positive Control (Mouse/Rat)
    Purity: >98.00%

    GAPDH siRNA Positive Control (Mouse/Rat), a siRNA product, is a mouse/rat GAPDH siRNA positive control.

  • GC81661 structure
    GC81661Anti-Mouse PD-1 Antibody (RMP1-14), CY7 labeled
    Purity: >98.00%

    Anti-Mouse PD-1 Antibody (RMP1-14), CY7 labeled, is an Anti-Mouse PD-1 Antibody (RMP1-14) derivative carrying dye CY7.

  • GC81662 structure
    GC81662nor-MC3
    CAS: 2870681-06-2
    Purity: >98.00%

    nor-MC3 is an MC3 -type ionizable lipid with C 17 unsaturated chains, formulated in lipid nanoparticles for nucleic acid ( mRNA and siRNA) delivery and supports in vitro and in vivo transfection [1] .

  • GC81667 structure
    GC8166713-Hydroxy-12-oxo-9(Z),15(Z)-octadecadienoic acid
    CAS: 70597-03-4
    Purity: >97.00%

    13-Hydroxy-12-oxo-9(Z),15(Z)-octadecadienoic acid is a fatty acid.

  • GC81668 structure
    GC81668Rodent Gnawing Blocks
    Purity: >98.00%

    Rodent Gnawing Blocks are irradiated and sterilized poplar blocks used for molarization in laboratory rodents such as mice and rats.

  • GC81669 structure
    GC81669ATP- 13 C 10 , 15 N 5 ,d 14 (dilithium)
    Purity: >98.00%

    ATP- 13 C 10, 15 N 5,d 14 ( Adenosine 5'-triphosphate- 13 C 10, 15 N 5,d 14 ) dilithium is the 13 C-, 15 N- and deuterium labeled ATP dilithium.

  • GC81670 structure
    GC8167015-Deoxy-Δ12,14-Prostaglandin J2-biotin
    Purity: >99.50%

    15-Deoxy-Δ12,14-Prostaglandin J2-biotin is a biotin-labled 15-Deoxy-Δ12,14-Prostaglandin J2.

  • GC81672 structure
    GC81672Senkyunolide B
    CAS: 93236-67-0
    Purity: >98.00%

    Senkyunolide B is a phthalide found in Angelica sinensis.

  • GC81673 structure
    GC81673UE01
    CAS: 486440-74-8
    Purity: >98.00%

    UE01 is an orally active, selective small-molecule modulator targeting both ULK1/ERK1/2.

  • GC81674 structure
    GC81674MKI-3
    CAS: 3084702-28-0
    Purity: >98.00%

    MKI-3 is a selective microtubule-associated serine/threonine kinase-like ( MASTL ) inhibitor with an IC 50 of 5.72 nM and a K d of 1.89 nM.

  • GC81675 structure
    GC81675MKI-2 hydrochloride
    Purity: >99.50%

    MKI-2 hydrochloride is a selective MASTL inhibitor with an IC 50 of 37.44 nM.

  • GC81676 structure
    GC81676Endosidin7
    CAS: 329072-88-0
    Purity: >98.00%

    Endosidin7 is a specific inhibitor for plant callose deposition during cytokinesis.

  • GC81677 structure
    GC81677APJ receptor agonist 10 free base
    CAS: 2415197-87-2
    Purity: >99.00%

    APJ receptor agonist 10 free base is an agonist of the APJ Receptor.

  • GC81678 structure
    GC81678ML278
    CAS: 1604821-43-3
    Purity: >97.50%

    ML278 is a scavenger receptor-BI ( SR-BI ) inhibitor with an IC 50 of 0.93 nM in mice.

  • GC81679 structure
    GC81679PLT012
    Purity: >98.50%

    PLT012 is a humanized IgG4 antibody targeting CD36.

  • GC81680 structure
    GC81680Antabactin
    CAS: 2570821-88-2
    Purity: >99.00%

    Antabactin is an ABA receptor antagonist.

  • GC81681 structure
    GC81681Pyroxsulam
    CAS: 422556-08-9
    Purity: >99.00%

    Pyroxsulam is a selective, foliar-applied acetolactate synthase ( ALS )-inhibiting herbicide.

  • GC81682 structure
    GC81682Sialorphin TFA
    Purity: >97.00%

    Sialorphin TFA is a neutral endopeptidase ( NEP ) and aminopeptidase N ( APN ) inhibitor that responds to androgen signals.

  • GC81683 structure
    GC81683AM9053
    CAS: 157469-21-1
    Purity: >98.00%

    AM9053 is a selective, effective and slowly reversible inhibitor of N-acyl ethanolamine acid amidease ( NAAA ) ( IC 50 = 30 nM).

  • GC81684 structure
    GC81684CK37
    CAS: 1001478-90-5
    Purity: >98.00%

    CK37 is a competitive choline kinase-α inhibitor.

  • GC81685 structure
    GC81685GDP-azido-fucose disodium
    CAS: 944560-34-3
    Purity: >99.50%

    GDP-azido-fucose disodium is a glycoengineering tool.

  • GC81686 structure
    GC81686Terbuthylazine-d 9
    CAS: 1346602-52-5
    Purity: >99.00%

    Terbuthylazine -d 9 is the deuterium labeled Terbuthylazine.

  • GC81687 structure
    GC81687cis-V-11-0711
    CAS: 1428338-79-7
    Purity: >98.00%

    cis-V-11-0711 is the cis form of V-11-0711.

  • GC81688 structure
    GC81688GSPT1 degrader-15
    CAS: 3060504-66-4
    Purity: >95.00%

    GSPT1 degrader-15 (Compound Lib-B-15O) is a potent and highly selective GSPT1 molecular gel degrader, with a DC 50 of 154 nM.